Florentino, Iziara F <br/><br/>
Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021).  [electronic resource] 

 -  Nitric oxide : biology and chemistry  May 2015 
 - 17-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1089-8611 
<br/><br/><label>Standard No.: </label>10.1016/j.niox.2015.02.146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Analgesics--administration & dosage<br/>Animals<br/>Cyclic GMP--metabolism<br/>Dose-Response Relationship, Drug<br/>KATP Channels--metabolism<br/>Male<br/>Mice<br/>Nitric Oxide--metabolism<br/>Pyrazoles--administration & dosage<br/>Receptors, Opioid--metabolism<br/>Tetrazoles--administration & dosage